Mouwasat Medical Services Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 2/6
Mouwasat Medical Services hat ein durchschnittliches jährliches Gewinnwachstum von 11.2% verzeichnet, während die Branche Healthcare ein Gewinnwachstum gewachsen unter 19.6% jährlich einen Rückgang. Die Umsätze sind gewachsen mit einer durchschnittlichen Rate von 8.8% pro Jahr. Mouwasat Medical Services's return on equity is 19.2%, und die Nettomargen betragen 24%.
Wichtige Informationen
11.2%
Wachstumsrate der Gewinne
11.2%
EPS-Wachstumsrate
| Healthcare Wachstum der Industrie | 12.3% |
| Wachstumsrate der Einnahmen | 8.8% |
| Eigenkapitalrendite | 19.2% |
| Netto-Marge | 24.0% |
| Letzte Ertragsaktualisierung | 31 Mar 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear
Apr 23
Here's Why We Think Mouwasat Medical Services (TADAWUL:4002) Might Deserve Your Attention Today
Mar 18Slowing Rates Of Return At Mouwasat Medical Services (TADAWUL:4002) Leave Little Room For Excitement
Jan 23Here's Why Mouwasat Medical Services (TADAWUL:4002) Has Caught The Eye Of Investors
Dec 17Mouwasat Medical Services (TADAWUL:4002) Has Some Way To Go To Become A Multi-Bagger
Oct 05Should You Be Adding Mouwasat Medical Services (TADAWUL:4002) To Your Watchlist Today?
Sep 17The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Jul 03Is Now The Time To Put Mouwasat Medical Services (TADAWUL:4002) On Your Watchlist?
Jun 12Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down
Feb 24Mouwasat Medical Services Company's (TADAWUL:4002) Intrinsic Value Is Potentially 25% Below Its Share Price
Jan 18Return Trends At Mouwasat Medical Services (TADAWUL:4002) Aren't Appealing
Nov 24Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down
Aug 24A Look At The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Jul 01Time To Worry? Analysts Just Downgraded Their Mouwasat Medical Services Company (TADAWUL:4002) Outlook
May 23Mouwasat Medical Services (TADAWUL:4002) Will Pay A Larger Dividend Than Last Year At ر.س2.75
Apr 29Mouwasat Medical Services (TADAWUL:4002) Is Increasing Its Dividend To ر.س2.75
Apr 15Investors Will Want Mouwasat Medical Services' (TADAWUL:4002) Growth In ROCE To Persist
Mar 17Calculating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Mar 02If You Like EPS Growth Then Check Out Mouwasat Medical Services (TADAWUL:4002) Before It's Too Late
Feb 15The Return Trends At Mouwasat Medical Services (TADAWUL:4002) Look Promising
Dec 06Do Mouwasat Medical Services's (TADAWUL:4002) Earnings Warrant Your Attention?
Nov 16Mouwasat Medical Services (TADAWUL:4002) Is Achieving High Returns On Its Capital
Aug 29Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
Aug 12Is Mouwasat Medical Services Company (TADAWUL:4002) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 29Mouwasat Medical Services' (TADAWUL:4002) Returns On Capital Are Heading Higher
May 26Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
May 11Is It Worth Buying Mouwasat Medical Services Company (TADAWUL:4002) For Its 1.4% Dividend Yield?
Apr 13Estimating The Intrinsic Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Mar 16Is Mouwasat Medical Services Company's (TADAWUL:4002) Latest Stock Performance Being Led By Its Strong Fundamentals?
Mar 02Is Mouwasat Medical Services (TADAWUL:4002) A Future Multi-bagger?
Feb 13Here's Why I Think Mouwasat Medical Services (TADAWUL:4002) Is An Interesting Stock
Feb 01
What Kind Of Shareholders Hold The Majority In Mouwasat Medical Services Company's (TADAWUL:4002) Shares?
Jan 17What Makes Mouwasat Medical Services Company (TADAWUL:4002) A Great Dividend Stock?
Jan 04Mouwasat Medical Services (TADAWUL:4002) Has Gifted Shareholders With A Fantastic 137% Total Return On Their Investment
Dec 21Estimating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Dec 08Mouwasat Medical Services Company's (TADAWUL:4002) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Nov 24Aufschlüsselung der Einnahmen und Ausgaben
Aufschlüsselung der Einnahmen und Ausgaben
Wie Mouwasat Medical Services Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 31 Mar 24 | 2,764 | 663 | 564 | 0 |
| 31 Dec 23 | 2,706 | 658 | 547 | 0 |
| 30 Sep 23 | 2,593 | 659 | 472 | 0 |
| 30 Jun 23 | 2,501 | 625 | 464 | 0 |
| 31 Mar 23 | 2,431 | 616 | 446 | 0 |
| 31 Dec 22 | 2,334 | 599 | 419 | 0 |
| 30 Sep 22 | 2,226 | 561 | 396 | 0 |
| 30 Jun 22 | 2,208 | 581 | 383 | 0 |
| 31 Mar 22 | 2,177 | 581 | 372 | 0 |
| 31 Dec 21 | 2,144 | 578 | 360 | 0 |
| 30 Sep 21 | 2,125 | 574 | 369 | 0 |
| 30 Jun 21 | 2,143 | 593 | 373 | 0 |
| 31 Mar 21 | 2,085 | 567 | 369 | 0 |
| 31 Dec 20 | 2,045 | 528 | 371 | 0 |
| 30 Sep 20 | 2,016 | 515 | 364 | 0 |
| 30 Jun 20 | 1,911 | 447 | 355 | 0 |
| 31 Mar 20 | 1,889 | 422 | 357 | 0 |
| 31 Dec 19 | 1,857 | 421 | 349 | 0 |
| 30 Sep 19 | 1,808 | 376 | 367 | 0 |
| 30 Jun 19 | 1,769 | 364 | 370 | 0 |
| 31 Mar 19 | 1,717 | 361 | 367 | 0 |
| 31 Dec 18 | 1,677 | 360 | 361 | 0 |
| 30 Sep 18 | 1,652 | 373 | 359 | 0 |
| 30 Jun 18 | 1,608 | 369 | 345 | 0 |
| 31 Mar 18 | 1,567 | 358 | 337 | 0 |
| 31 Dec 17 | 1,507 | 337 | 334 | 0 |
| 30 Sep 17 | 1,435 | 314 | 318 | 0 |
| 30 Jun 17 | 1,356 | 286 | 307 | 0 |
| 31 Mar 17 | 1,303 | 274 | 296 | 0 |
| 31 Dec 16 | 1,243 | 257 | 284 | 0 |
| 30 Sep 16 | 1,144 | 235 | 254 | 0 |
| 30 Jun 16 | 1,095 | 229 | 236 | 0 |
| 31 Mar 16 | 1,050 | 221 | 220 | 0 |
| 31 Dec 15 | 1,000 | 209 | 209 | 0 |
| 30 Sep 15 | 926 | 206 | 157 | 0 |
| 30 Jun 15 | 925 | 235 | 167 | 0 |
| 31 Mar 15 | 914 | 238 | 175 | 0 |
| 31 Dec 14 | 904 | 240 | 179 | 0 |
| 30 Sep 14 | 961 | 240 | 245 | 0 |
| 30 Jun 14 | 942 | 212 | 242 | 0 |
| 31 Mar 14 | 927 | 207 | 238 | 0 |
| 31 Dec 13 | 902 | 201 | 229 | 0 |
| 30 Sep 13 | 873 | 193 | 218 | 0 |
| 30 Jun 13 | 848 | 185 | 210 | 0 |
Qualität der Erträge: 4002 hat hohe Qualitätseinkünfte.
Wachsende Gewinnspanne: 4002Die aktuellen Gewinnspannen (24%) sind niedriger als im letzten Jahr (25.3%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 4002In den letzten 5 Jahren sind die Gewinne von 11.2% jährlich gestiegen.
Beschleunigtes Wachstum: 4002Das Gewinnwachstum des Unternehmens im letzten Jahr (7.6%) liegt unter seinem 5-Jahres-Durchschnitt (11.2% pro Jahr).
Erträge im Vergleich zur Industrie: 4002 Das Gewinnwachstum im vergangenen Jahr (7.6%) übertraf nicht die Entwicklung der Branche Healthcare 20.5%.
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 4002Die Eigenkapitalrendite des Unternehmens (19.2%) wird als niedrig angesehen.